Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corcept Therapeutics (CORT) Long-Term Investments: 2017-2025

Historic Long-Term Investments for Corcept Therapeutics (CORT) over the last 7 years, with Sep 2025 value amounting to $102.6 million.

  • Corcept Therapeutics' Long-Term Investments fell 38.70% to $102.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $102.6 million, marking a year-over-year decrease of 38.70%. This contributed to the annual value of $219.8 million for FY2024, which is 284.48% up from last year.
  • Corcept Therapeutics' Long-Term Investments amounted to $102.6 million in Q3 2025, which was down 40.64% from $172.8 million recorded in Q2 2025.
  • Over the past 5 years, Corcept Therapeutics' Long-Term Investments peaked at $248.0 million during Q1 2025, and registered a low of $4.9 million during Q3 2022.
  • Over the past 3 years, Corcept Therapeutics' median Long-Term Investments value was $102.6 million (recorded in 2025), while the average stood at $120.8 million.
  • Per our database at Business Quant, Corcept Therapeutics' Long-Term Investments surged by 2,320.40% in 2021 and then slumped by 96.34% in 2022.
  • Corcept Therapeutics' Long-Term Investments (Quarterly) stood at $112.3 million in 2021, then slumped by 95.59% to $4.9 million in 2022, then skyrocketed by 1,055.77% to $57.2 million in 2023, then spiked by 284.48% to $219.8 million in 2024, then tumbled by 38.70% to $102.6 million in 2025.
  • Its Long-Term Investments was $102.6 million in Q3 2025, compared to $172.8 million in Q2 2025 and $248.0 million in Q1 2025.